T-cell receptor complex (TCR complex) (TCR)

The T-cell receptor (TCR) complex is a multi-subunit protein assembly found on the surface of T lymphocytes, including CD4+ and CD8+ subsets [1][2]. It consists of a variable antigen-recognition heterodimer, typically alpha and beta chains, non-covalently associated with invariant CD3 signaling modules (epsilon, delta, gamma, and zeta) [1][3]. The primary function of the TCR complex is to recognize peptide antigens presented by major histocompatibility complex (MHC) molecules on the surface of other cells [2]. Upon antigen binding, the complex initiates intracellular signaling cascades that govern T-cell activation, differentiation, and effector functions [3][4].\n\nIn autoimmune diseases, the TCR complex is often involved in the inappropriate recognition of self-antigens, while in cancer, it is a primary target for immunotherapies designed to enhance the immune response against malignant cells [4][5]. Therapeutic agents include monoclonal antibodies that modulate CD3 to suppress immune responses in transplantation or diabetes, as well as TCR-engineered T-cell (TCR-T) therapies and bispecific T-cell engagers (BiTEs) that redirect T-cell cytotoxicity toward specific tumor markers [5][6]. Safety concerns associated with TCR-targeting therapies often involve systemic inflammatory responses, such as cytokine release syndrome [7].

Other names

TCR-CD3 complexT-cell antigen receptorT-cell receptor

The TCR complex is targeted via monoclonal antibodies to either deplete T cells or modulate signaling for immunosuppression, or via engineered T-cell therapies and bispecific engagers to redirect T-cell cytotoxicity against specific antigens.